Cytodyn Inc (CYDY)

[JPG77]

"Scott Kelly: Regarding the NASH, about how NASH attracted partnerships, we just presented the PDFF and cT1 and biomarker data at EASL in London, just to shed some color on the importance of the EASL meeting, there were over 7,000 delegates present or online from 114 countries. There were 1,722 abstracts presented. There were only 4 poster presentations selected for a walking tour with the chairman at EASL. And We were one of those 4. I was present and I can tell you, it was well received by the scientific community. We cannot comment on potential partnerships. But there are multiple opportunities for NASH and NASH HIV."

So, you're saying this was a waste of company funds???

#2--Flew s kelly to London